DARAPRIM cpr 25 mg 30 pce
7680209640011
CH-20964
P01BD01
08.04.3.
Reimbursement limitations:
MALARIA
Utilisation à des fins prophylactiques non admise à la charge des assureurs-maladie.
1 / 3
google
Details
- Product number
- 2096401
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- pyrimethaminum 25 mg, lactosum monohydricum 90 mg, maydis amylum, amylum hydrolysatum, magnesii stearas, natrii docusas, pro compresso corresp. natrium 0.0006 mg.
Articles (1)
Daraprim, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
90.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.0006 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 31.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1962
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 20964
- Drug name
- Daraprim, Tabletten
- Galenic form
- TAB
- ATC Code
- P01BD01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 22/02/1955
- Authorization expiration date
- 31/12/9999
- IT number
- 08.04.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DARAPRIM cpr 25 mg 30 pce
- Description (DE)
- DARAPRIM Tabl 25 mg 30 Stk
- Market launch
- 22/02/1955
- Narcotic (BTM)
- No